Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Truseltiq
Truseltiq
$2.4B BridgeBio/Helsinn Liver Cancer Deal Falls Apart
BioSpace
Thu, 10/13/22 - 11:53 pm
BridgeBio
Helsinn
liver cancer
Truseltiq
BridgeBio keeps FDA approval spree rolling, this time with nod for targeted bile duct cancer med
Fierce Pharma
Tue, 06/1/21 - 12:07 pm
Bridge Bio
FDA
Truseltiq
infigratinib
bile duct cancer